

Author: Lobmaier Philipp Paul Kunøe Nikolaj Waal Helge
Publisher: Informa Healthcare
ISSN: 1606-6359
Source: Addiction Research and Theory, Vol.18, Iss.1, 2010-06, pp. : 1-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




By Pollack Mark Mangano Richard Entsuah Richard Tzanis Evan Simon Naomi
Psychopharmacology, Vol. 194, Iss. 2, 2007-10 ,pp. :






Assessment of Agents for the Treatment of Head Injury: Problems and Pitfalls in Trial Design
By Maas A.I.R.
CNS Drugs, Vol. 13, Iss. 2, 2000-02 ,pp. :